Berkeley, CA, United States of America

Paul Daniel Donohoue

USPTO Granted Patents = 45 

 

 

Average Co-Inventor Count = 2.3

ph-index = 13

Forward Citations = 497(Granted Patents)


Location History:

  • Berkeley, CA (US) (2016 - 2022)
  • Albany, CA (US) (2021 - 2022)
  • San Diego, CA (US) (2022 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
45 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Paul Daniel Donohoue's Remarkable Career in Revolutionizing Industries

Introduction:

Throughout his illustrious career, Paul Daniel Donohoue has consistently demonstrated his immense talent and passion for innovation. Hailing from Berkeley, CA (US), Donohoue has made a significant impact on various industries through his groundbreaking solutions. His dedication to engineering novel technologies has led to the development of numerous patented inventions that have revolutionized the way we approach complex challenges.

Latest Patents:

Donohoue's latest patents showcase his impressive range of expertise and his relentless drive to push the boundaries of scientific discovery. One such groundbreaking invention is "Engineered nucleic acid-targeting nucleic acids." This patent describes engineered polynucleotide sequences that form scaffolds and nucleoprotein complexes, as well as related expression cassettes, vectors, and cells. These innovations hold great promises for advancements in nucleic acid research and their application in various fields.

In addition, Donohoue has also contributed significantly to the field of gene editing with his patent on "CRISPR CPF1 hybrid DNA/RNA polynucleotides." This invention encompasses DNA-guided CRISPR systems and polynucleotides comprising DNA, RNA, and both. These advancements highlight the potential of CRISPR technology in precision genetic engineering, paving the way for transformative breakthroughs in healthcare, agriculture, and beyond.

Career Highlights:

Paul Daniel Donohoue's career is characterized by remarkable achievements and milestones. His work at Caribou Biosciences, Inc. and Pioneer Hi-bred International, Inc. reflects his commitment to leveraging his expertise in novel ways. At Caribou Biosciences, Donohoue contributed to cutting-edge gene editing technologies, while his time at Pioneer Hi-bred International, Inc. focused on advancements in plant genetic engineering. His diverse experiences have equipped him with a multifaceted approach to innovation, leading to his exceptional success.

Collaborations:

Donohoue's collaborative efforts have further propelled his achievements and solidified his standing as a renowned innovator. He has worked alongside esteemed colleagues such as Andrew Paul May and Matthew Merrill Carter, who have made significant contributions in their respective fields. These collaborations have fostered an environment of knowledge exchange and innovation, leading to groundbreaking discoveries and pioneering inventions.

Conclusion:

In conclusion, Paul Daniel Donohoue's remarkable career stands as a testament to his relentless pursuit of innovation and his profound impact on numerous industries. His groundbreaking patents, such as the engineered nucleic acid-targeting nucleic acids and CRISPR CPF1 hybrid DNA/RNA polynucleotides, exemplify his ability to envision solutions that push scientific boundaries. Through his collaborations and career highlights, Donohoue has not only revolutionized industries but also improved the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…